Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 3
2004 2
2005 4
2006 2
2007 3
2008 8
2009 6
2010 7
2011 1
2012 4
2013 2
2014 4
2015 7
2016 5
2017 6
2018 9
2019 3
2020 5
2021 6
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
Jeger RV, Farah A, Ohlow MA, Mangner N, Möbius-Winkler S, Leibundgut G, Weilenmann D, Wöhrle J, Richter S, Schreiber M, Mahfoud F, Linke A, Stephan FP, Mueller C, Rickenbacher P, Coslovsky M, Gilgen N, Osswald S, Kaiser C, Scheller B; BASKET-SMALL 2 Investigators. Jeger RV, et al. Lancet. 2018 Sep 8;392(10150):849-856. doi: 10.1016/S0140-6736(18)31719-7. Epub 2018 Aug 28. Lancet. 2018. PMID: 30170854 Free article. Clinical Trial.
Risk prediction in theory and practice.
Hoffmann A. Hoffmann A. Eur J Prev Cardiol. 2023 Jan 11;30(1):6-7. doi: 10.1093/eurjpc/zwac216. Eur J Prev Cardiol. 2023. PMID: 36125218 No abstract available.
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
Jeger RV, Farah A, Ohlow MA, Mangner N, Möbius-Winkler S, Weilenmann D, Wöhrle J, Stachel G, Markovic S, Leibundgut G, Rickenbacher P, Osswald S, Cattaneo M, Gilgen N, Kaiser C, Scheller B; BASKET-SMALL 2 Investigators. Jeger RV, et al. Lancet. 2020 Nov 7;396(10261):1504-1510. doi: 10.1016/S0140-6736(20)32173-5. Epub 2020 Oct 19. Lancet. 2020. PMID: 33091360 Clinical Trial.
How much is too much?
Hoffmann A. Hoffmann A. Eur J Prev Cardiol. 2017 Sep;24(13):1445. doi: 10.1177/2047487317716235. Epub 2017 Jun 14. Eur J Prev Cardiol. 2017. PMID: 28610441 No abstract available.
[Cardiac Rehabilitation 2015].
Hoffmann A. Hoffmann A. Praxis (Bern 1994). 2015 Nov 25;104(24):1317-22. doi: 10.1024/1661-8157/a002193. Praxis (Bern 1994). 2015. PMID: 26602848 Review. German.
Humans are not meant to live alone.
Hoffmann A. Hoffmann A. Eur J Prev Cardiol. 2022 Jan 11;28(16):e14. doi: 10.1177/2047487320920757. Eur J Prev Cardiol. 2022. PMID: 33611535 No abstract available.
Low-Temperature Synthesis of Titanium Oxynitride Nanoparticles.
Jansen F, Hoffmann A, Henkel J, Rahimi K, Caumanns T, Kuehne AJC. Jansen F, et al. Among authors: hoffmann a. Nanomaterials (Basel). 2021 Mar 26;11(4):847. doi: 10.3390/nano11040847. Nanomaterials (Basel). 2021. PMID: 33810321 Free PMC article.
Generation of Large Vortex-Free Superfluid Helium Nanodroplets.
Ulmer A, Heilrath A, Senfftleben B, O'Connell-Lopez SMO, Kruse B, Seiffert L, Kolatzki K, Langbehn B, Hoffmann A, Baumann TM, Boll R, Chatterley AS, De Fanis A, Erk B, Erukala S, Feinberg AJ, Fennel T, Grychtol P, Hartmann R, Ilchen M, Izquierdo M, Krebs B, Kuster M, Mazza T, Montaño J, Noffz G, Rivas DE, Schlosser D, Seel F, Stapelfeldt H, Strüder L, Tiggesbäumker J, Yousef H, Zabel M, Ziołkowski P, Meyer M, Ovcharenko Y, Vilesov AF, Möller T, Rupp D, Tanyag RMP. Ulmer A, et al. Among authors: hoffmann a. Phys Rev Lett. 2023 Aug 18;131(7):076002. doi: 10.1103/PhysRevLett.131.076002. Phys Rev Lett. 2023. PMID: 37656857
89 results